Description
B7-2, also known as cluster of differentiation 86 (CD86), is a cell surface glycoprotein expressed on antigen-presenting cells (APCs) and plays a crucial role in regulating adaptive immune responses. As co-stimulatory molecule, B7-2 binds to CD28 expressed on the surface of T cells and thereby, provides a second signal that is inevitable for T cell activation, proliferation and differentiation into effector and memory T cells. Inhibitory signals induced by interaction of B7-2 with the cytotoxic T lymphocyte antigen-4 (CTLA-4) limit initial T cell activation in secondary lymphoid organs in order to prevent excessive immune stimulation. Modulating the B7-2/CD28 and B7-2/CTLA-4 interactions can have significant effects on immune responses and thus, represents a promising strategy to treat various autoimmune diseases and cancer.
-
Product Name: human B7-2/CD86
-
Catalog No.: P2020-151: GFP/His-Tag, P2020-152: Fc/His-Tag, P2020-153: His-Tag
-
RefSeq Links: UniProt: P42081; HGNC:1705; NX_P42081; NP_787058.4; NM_175862.4; PDBe 8hxb
-
Synonyms: CD86, CD86 antigen, T-lymphocyte activation antigen CD86, B7-2, Activation B7-2 antigen, B70, BU63, CTLA-4 counter-receptor B7.2, FUN-1, CD28LG2, LAB72, MGC34413